Dr Lance M. Roasa

Medical Brief: PIK3CA and KRAS Mutations Predict for Response to Everolimus Therapy

August 02, 2021

Medical Brief: Histiocytic Sarcoma

July 26, 2021

Medical Brief: Treatment of Canine Cutaneous Epitheliotropic T-cell lymphoma with Olacitinib

July 12, 2021

An Interview with Scientific Advisory Board Member: Dr. Corrie Painter

June 30, 2021

Topics

One post • CEO of Flatwater Veterinary Group,  P.C. & Co-founder of Drip.vet

Featuring

Dr. Gerry Post, The Internet

Dr Lance M. Roasa, CEO of Flatwater Veterinary Group,  P.C. & Co-founder of Drip.vet

The Rise of Veterinary Telemedicine Amidst the COVID-19 Pandemic, Part 2

Telemedicine in veterinary care experienced a boom with the COVID-19 pandemic. Dr. Lance M. Roasa joins us to examine the path ahead for telemedicine in veterinary care.

Dr. Gerry Post Dr Lance M. Roasa

Jun 10 • 6 min read

Webinars

Discover more content...

Enter some keywords in the search box above, we will do our best to offer you relevant results.

Results

We're sorry!

We couldn't find any results for your search. Please try again with another keywords.

Success! Your account is fully activated, you now have access to all content.

Recent articles

Medical Brief: PIK3CA and KRAS Mutations Predict for Response to Everolimus Therapy

Medical Brief: Histiocytic Sarcoma

Medical Brief: Treatment of Canine Cutaneous Epitheliotropic T-cell lymphoma with Olacitinib

An Interview with Scientific Advisory Board Member: Dr. Corrie Painter

Topics

Dr Lance M. Roasa

The Rise of Veterinary Telemedicine Amidst the COVID-19 Pandemic, Part 2

Discover more content...

Results

We're sorry!

Recent articles

Medical Brief: PIK3CA and KRAS Mutations Predict for Response to Everolimus Therapy

Medical Brief: Histiocytic Sarcoma

Medical Brief: Treatment of Canine Cutaneous Epitheliotropic T-cell lymphoma with Olacitinib

An Interview with Scientific Advisory Board Member: Dr. Corrie Painter

Topics